EMITT-1 investigational therapy (ERAP Mediated Immunopeptidome Targeting)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EMITT-1 investigational therapy (ERAP Mediated Immunopeptidome Targeting), covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) [Phase 1, Phase 2]